Accord Pharmaceuticals to issue IPO
Accord Pharmaceuticals Limited is going to issue 480,000 IPO lots to the public. The company has appointed Global IME Capital as the issue and sale manager for the public issue of 480,000 ordinary shares at a face value of Rs 100 per share.
In this regard, an agreement has been reached between the company and Capital regarding the issue of shares. The agreement was signed by Chairman Vishal Pandit on behalf of Accord Pharmaceuticals and Chief Executive Officer
Paras Mani Dhakal on behalf of Global IME Capital at a function held at Global IME Capital’s central office Naxal on December 7.With an authorized capital of Rs. 650 million and an issued capital of Rs.
Provided by people who have been involved in the business of medicines and pharmaceutical products in Nepal for a long time and experts in various fields, this pharmaceutical company was formally established in the year 2070 BS and later transformed into a public limited company.
The pharmaceutical production building has been constructed in accordance with the standards and guidelines of the World Health Organization and the management, connection and production process of the equipment has been ensured accordingly.
With a total built-up area of 60,000 sq. Ft., The industry has brought to the market specific and diverse quality medicines from the building of the industry.
Among the many companies currently producing drugs in the country, this pharmaceuticals company is the first pharmaceutical company in Nepal to issue shares to the public.